We are live on ! Find out more
HMC

Harvard Management Company Portfolio holdings

AUM $1.82B
1-Year Est. Return 26.23%
This Fund
S&P 500
This Quarter Est. Return
+4.45%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$886M
AUM Growth
-$133M
Cap. Flow
-$156M
Cap. Flow %
-17.57%
Top 10 Hldgs %
96.5%
Holding
34
New
1
Increased
–
Reduced
4
Closed
12

Top Buys

Rank Stock Value
1
CART icon
Maplebear
CART
+$15.8M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$87M
2
META icon
Meta Platforms (Facebook)
META
+$53.5M
3
EQRX
EQRx, Inc. Common Stock
EQRX
+$7.17M
4
RXRX icon
Recursion Pharmaceuticals
RXRX
+$6.59M
5
NRIX icon
Nurix Therapeutics
NRIX
+$3.14M

Sector Composition

Rank Sector Weight
1 Communication Services 58.17%
2 Consumer Discretionary 23.31%
3 Technology 13.87%
4 Healthcare 2.34%
5 Industrials 0.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRON icon
26
Disc Medicine
IRON
$3.03B
– –
-8,452
Closed -$375K
NRIX icon
27
Nurix Therapeutics
NRIX
$2.61B
– –
-314,762
Closed -$3.14M
PACB icon
28
Pacific Biosciences
PACB
$404M
– –
-233,186
Closed -$3.1M
PRAX icon
29
Praxis Precision Medicines
PRAX
$8.9B
– –
-46,174
Closed -$797K
RXRX icon
30
Recursion Pharmaceuticals
RXRX
$1.68B
– –
-882,129
Closed -$6.59M
KNTE
31
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
– –
-462,418
Closed -$1.4M
EQRX
32
DELISTED
EQRx, Inc. Common Stock
EQRX
– –
-3,853,367
Closed -$7.17M
DBTX
33
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
– –
-326,029
Closed -$1.25M
PRDS
34
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
– –
-400,000
Closed -$724K
1
2

Similar funds

DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return
SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return
RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return

Harvard Management Company's Q3 2023 Portfolio in Review

As of Q3 2023, Harvard Management Company held 34 positions worth $886M, down 13% from $1.02B the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Harvard Management Company withdrew a net $156M in Q3 2023, closing 12 positions and reducing 4 holdings. Its most notable exit was EQRx, Inc. Common Stock, an estimated $7.17M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 58% of assets, down from 60% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Harvard Management Company opened a new position in Maplebear worth $15.4M.

  • Harvard Management Company's largest Q3 2023 buy was Maplebear: 519,838 shares worth $15.4M.
  • Harvard Management Company's biggest Q3 2023 reduction was Alphabet (Google) Class A, cutting an estimated $87M.
  • Harvard Management Company fully exited EQRx, Inc. Common Stock in Q3 2023, selling an estimated $7.17M.
  • Harvard Management Company's ten largest holdings make up 96% of its $886M portfolio in Q3 2023.
  • Harvard Management Company opened 1 new position and closed 12 in Q3 2023.
  • Harvard Management Company's portfolio value fell 13% quarter-over-quarter to $886M.

Based on Harvard Management Company's 13F filing for Q3 2023, filed 9 Nov 2023.